Alyeska Investment Group L.P. Has $181.72 Million Holdings in Danaher Co. (NYSE:DHR)

Alyeska Investment Group L.P. lifted its holdings in Danaher Co. (NYSE:DHR - Free Report) by 178.5% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 791,615 shares of the conglomerate's stock after purchasing an additional 507,323 shares during the period. Danaher accounts for approximately 0.7% of Alyeska Investment Group L.P.'s portfolio, making the stock its 23rd biggest holding. Alyeska Investment Group L.P. owned 0.11% of Danaher worth $181,715,000 at the end of the most recent quarter.

Several other large investors have also made changes to their positions in DHR. Kentucky Retirement Systems Insurance Trust Fund grew its holdings in shares of Danaher by 11.6% during the 4th quarter. Kentucky Retirement Systems Insurance Trust Fund now owns 21,233 shares of the conglomerate's stock worth $4,874,000 after purchasing an additional 2,202 shares in the last quarter. FAS Wealth Partners Inc. boosted its stake in Danaher by 20.6% during the fourth quarter. FAS Wealth Partners Inc. now owns 9,597 shares of the conglomerate's stock worth $2,203,000 after buying an additional 1,639 shares in the last quarter. ORG Partners LLC raised its stake in shares of Danaher by 1,212.8% in the 4th quarter. ORG Partners LLC now owns 2,770 shares of the conglomerate's stock valued at $636,000 after buying an additional 2,559 shares in the last quarter. Generate Investment Management Ltd bought a new position in shares of Danaher during the 4th quarter worth about $8,044,000. Finally, Compass Capital Management Inc. increased its stake in Danaher by 4.8% in the fourth quarter. Compass Capital Management Inc. now owns 237,922 shares of the conglomerate's stock valued at $54,615,000 after acquiring an additional 10,994 shares during the period. Institutional investors and hedge funds own 79.05% of the company's stock.

Wall Street Analysts Forecast Growth

A number of analysts have weighed in on the company. The Goldman Sachs Group lowered their price target on Danaher from $260.00 to $240.00 and set a "neutral" rating on the stock in a research report on Wednesday, April 23rd. Barclays raised their price objective on shares of Danaher from $205.00 to $215.00 and gave the stock an "overweight" rating in a report on Tuesday, April 22nd. Raymond James restated a "market perform" rating on shares of Danaher in a research report on Monday, February 3rd. Robert W. Baird reduced their price objective on Danaher from $231.00 to $225.00 and set an "outperform" rating on the stock in a research note on Wednesday, April 23rd. Finally, JPMorgan Chase & Co. lowered their target price on Danaher from $280.00 to $260.00 and set an "overweight" rating for the company in a research note on Tuesday, April 22nd. Five analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the company. According to data from MarketBeat, Danaher has an average rating of "Moderate Buy" and an average target price of $264.40.

Danaher Trading Down 3.7 %

Shares of Danaher stock traded down $7.29 during trading on Tuesday, reaching $190.11. 3,826,473 shares of the company were exchanged, compared to its average volume of 3,378,475. Danaher Co. has a twelve month low of $171.00 and a twelve month high of $281.70. The business has a 50-day moving average price of $199.54 and a 200-day moving average price of $220.89. The company has a quick ratio of 1.05, a current ratio of 1.40 and a debt-to-equity ratio of 0.31. The firm has a market capitalization of $136.06 billion, a price-to-earnings ratio of 36.01, a P/E/G ratio of 2.66 and a beta of 0.80.

Danaher (NYSE:DHR - Get Free Report) last announced its quarterly earnings results on Tuesday, April 22nd. The conglomerate reported $1.88 earnings per share for the quarter, beating analysts' consensus estimates of $1.62 by $0.26. Danaher had a net margin of 16.33% and a return on equity of 10.82%. The business had revenue of $5.74 billion for the quarter, compared to the consensus estimate of $5.58 billion. Sell-side analysts anticipate that Danaher Co. will post 7.63 EPS for the current fiscal year.

Danaher Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, July 25th. Shareholders of record on Friday, June 27th will be issued a $0.32 dividend. This represents a $1.28 annualized dividend and a dividend yield of 0.67%. Danaher's dividend payout ratio (DPR) is currently 24.85%.

Insider Activity at Danaher

In related news, EVP Christopher Paul Riley sold 15,805 shares of the business's stock in a transaction that occurred on Wednesday, April 30th. The stock was sold at an average price of $198.00, for a total value of $3,129,390.00. Following the completion of the sale, the executive vice president now directly owns 15,179 shares in the company, valued at approximately $3,005,442. The trade was a 51.01 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this link. 11.10% of the stock is currently owned by insiders.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.